Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

Bibliographic Details
Main Authors: Joulain, F, Proskorovsky, I, Allegra, C, Tabernero, J, Hoyle, M, Iqbal, S U, Van Cutsem, E
Format: Online
Language:English
Published: Nature Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790175/
id pubmed-3790175
recordtype oai_dc
spelling pubmed-37901752013-10-21 Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer Joulain, F Proskorovsky, I Allegra, C Tabernero, J Hoyle, M Iqbal, S U Van Cutsem, E Clinical Study Nature Publishing Group 2013-10-01 2013-09-17 /pmc/articles/PMC3790175/ /pubmed/24045663 http://dx.doi.org/10.1038/bjc.2013.523 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Joulain, F
Proskorovsky, I
Allegra, C
Tabernero, J
Hoyle, M
Iqbal, S U
Van Cutsem, E
spellingShingle Joulain, F
Proskorovsky, I
Allegra, C
Tabernero, J
Hoyle, M
Iqbal, S U
Van Cutsem, E
Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
author_facet Joulain, F
Proskorovsky, I
Allegra, C
Tabernero, J
Hoyle, M
Iqbal, S U
Van Cutsem, E
author_sort Joulain, F
title Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
title_short Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
title_full Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
title_fullStr Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
title_full_unstemmed Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
title_sort mean overall survival gain with aflibercept plus folfiri vs placebo plus folfiri in patients with previously treated metastatic colorectal cancer
description
publisher Nature Publishing Group
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790175/
_version_ 1612016231068467200

Similar Items